Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox

ClinicalTrials.gov ID: NCT00668304

Public ClinicalTrials.gov record NCT00668304. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective, Multicenter, Open, Uncontrolled Trial to Evaluate the Time to Bacterial Eradication and Key Symptom Relief in the Treatment of Acute Bacterial Maxillary Sinusitis With Moxifloxacin 400 mg QD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study evaluated the time to bacteriological eradication of common pathogens during moxifloxacin therapy for acute bacterial maxillary sinusitis. The study also examined the time to resolution of key symptoms associated with sinusitis.

Study identification

NCT ID
NCT00668304
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bayer
Industry
Enrollment
192 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2004 (Type not available)
Primary completion
Not listed
Completion
Jan 2005 (Actual)
Last update posted
Dec 19, 2014

2004 – 2005

United States locations

U.S. sites
29
U.S. states
19
U.S. cities
29
Facility City State ZIP Site status
Not listed Birmingham Alabama 35206 —
Not listed Hoover Alabama 35216-5453 —
Not listed Jonesboro Arkansas 72401 —
Not listed Searcy Arkansas 72143 —
Not listed Fresno California 93720 —
Not listed Riverside California 92506 —
Not listed San Francisco California 94102 —
Not listed Colorado Springs Colorado 80909 —
Not listed Longmont Colorado 80501 —
Not listed Bridgeport Connecticut 06606 —
Not listed DeLand Florida 32720-2560 —
Not listed Shreveport Louisiana 71105 —
Not listed Detroit Michigan 48202 —
Not listed North Massapequa New York 11758 —
Not listed Rochester New York 14618 —
Not listed Columbus Ohio 43235 —
Not listed Oklahoma City Oklahoma 73120 —
Not listed Yukon Oklahoma 73099 —
Not listed Lake Oswego Oregon 97035 —
Not listed Harrisburg Pennsylvania 17110 —
Not listed Greenville South Carolina 29607 —
Not listed Orangeburg South Carolina 29118 —
Not listed Jackson Tennessee 38301 —
Not listed Carrollton Texas 75010 —
Not listed Salt Lake City Utah 84102 —
Not listed Charlottesville Virginia 22902 —
Not listed Richmond Virginia 23229 —
Not listed Winchester Virginia 22601 —
Not listed Spokane Washington 99202-1334 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00668304, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 19, 2014 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00668304 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →